Medicamen Biotech Limited, a leading pharmaceutical company, has issued a Corrigendum to the Notice of the Extra-Ordinary General Meeting (EGM) dated February 26, 2025. This corrigendum notifies shareholders about modifications in the explanatory statement pertaining to Item No. 1 and 2 of the EGM notice. The corrigendum has been issued in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has been duly communicated to the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE).

Key Changes in the Explanatory Statement

The corrigendum highlights the following modifications to the explanatory statement in the EGM Notice:

1. Object Number b):

   • The original heading of object number b) included the term “etc.” which has now been deleted.
   • The revised heading reads as:
     b) Registration of dossiers

2. Object Number d):

   • The phrase “in some area of upgradation” under the heading of object number d) has been removed.
   • The revised heading reads as:
     d) Capital expenditure of the existing facilities

3. Object Number e), Subpoint (3):

   • The subpoint (3), which earlier mentioned “Increased participation in domestic medical conferences to enhance brand recognition and engagement with healthcare professionals,” has been deleted.

Revisions in the Utilization of Proceeds

As a result of these changes, the table under the heading Utilization of Proceeds in the EGM Notice has been updated to reflect the following:

• Point 2: Registration of dossiers
• Point 4: Capital expenditure of the existing facilities

All other particulars and details mentioned in the EGM Notice remain unchanged. The corrigendum is to be read in conjunction with the EGM Notice dated February 26, 2025, and the accompanying explanatory statement.

Availability of the Corrigendum

The corrigendum has been made available on multiple platforms to ensure easy access for shareholders. The document can be accessed on the following platforms:

• Company Website: www.medicamen.com
• National Stock Exchange of India Limited (NSE): www.nseindia.com
• BSE Limited (BSE): www.bseindia.com
• Registrar and Transfer Agent (MUFG Intime India Private Limited): www.in.mpms.mufg.com

Communication with Shareholders

To ensure transparency and timely communication, the corrigendum has also been sent electronically to all registered shareholders of the company. This ensures that all shareholders are adequately informed about the updates before the scheduled EGM.

Background on the EGM Notice

The original EGM Notice dated February 26, 2025, sought approval from members on specific agenda items, including preferential issues and capital expenditure plans. The notice was circulated in compliance with the provisions of the Companies Act, 2013 and the rules made thereunder.

Date and Mode of EGM

The Extra-Ordinary General Meeting (EGM) is scheduled to be held on:

• Date: Wednesday, March 26, 2025
• Time: 12:00 PM (IST)
• Mode: Through Video Conferencing (VC)/Other Audio-Visual Means (OAVM)

Importance of the Corrigendum

The issuance of this corrigendum reflects the company’s commitment to maintaining transparency and ensuring that shareholders are kept fully informed of any changes that may impact their decision-making process. The modifications in the explanatory statement provide a more accurate and clear understanding of the agenda items proposed in the EGM.

Commitment to Regulatory Compliance

Medicamen Biotech Limited continues to uphold its commitment to complying with the SEBI Listing Regulations and ensuring that all necessary disclosures and regulatory intimations are made in a timely and accurate manner.

Next Steps for Shareholders

Shareholders are encouraged to carefully review the corrigendum and consider the modifications while making their decisions during the EGM. Any further updates or changes will be promptly communicated through the company’s official communication channels.

For further information, shareholders can visit the company’s website or refer to the respective websites of NSE, BSE, and the Registrar and Transfer Agent (MIIPL).

The Upcoming IPOs in this week and coming weeks are Arisinfra Solutions Limited,Rapid Fleet Management Services, Active Infrastructures Limited, Desco Infratech Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited.

The Current active IPO are Grand Continental Hotels.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.